Literature DB >> 31577215

Vaccination coverage in children with rheumatic diseases.

Maša Bizjak1, Štefan Blazina2, Mojca Zajc Avramovič2, Gašper Markelj2, Tadej Avčin2, Nataša Toplak3.   

Abstract

OBJECTIVES: To assess vaccination status in a cohort of children with rheumatic diseases followed at the University Children's Hospital Ljubljana and to evaluate the most common reasons for vaccination dropout.
METHODS: Patients with rheumatic diseases who were evaluated at the rheumatology outpatient clinic between January 2015 and January 2017 received a questionnaire about their vaccination status and reasons for potential vaccination dropout. Vaccination coverage for individual vaccines was determined at 5, 10, 18 years and at the time of their last clinic visit.
RESULTS: Data were received from 187 out of 424 enrolled patients (44.1%). Majority of included patients had juvenile idiopathic arthritis (n=165), followed by childhood-onset systemic lupus erythematosus (n=6), juvenile dermatomyositis (n=5), mixed connective tissue disease (n=3), chronic recurrent multifocal osteomyelitis, juvenile systemic sclerosis, Takayasu's arteritis (n=2 each), granulomatous polyangiitis and fibromyalgia (n=1 each). Vaccination coverage was complete in 91.9%, 70.3%, 66.7% and 64.7% of patients at 5, 10, 18 years and at their last clinic visit, respectively. Most commonly omitted vaccines were hepatitis B and second dose of measles, mumps and rubella vaccine. Most common additional vaccine was against rotavirus. Most common reason for vaccination dropout was suggestion of the treating rheumatologist.
CONCLUSIONS: Thirty-five percent of our patients remain incompletely vaccinated and thus susceptible to vaccine-preventable diseases. Physicians play a crucial role in the decision to vaccinate.

Entities:  

Year:  2019        PMID: 31577215

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  7 in total

1.  Suboptimal vaccination coverage of recommended vaccines among French children with recurrent autoinflammatory fever syndromes: a study from the Juvenile Inflammatory Rheumatism cohort.

Authors:  Virginie Rollet-Cohen; Justine Mirete; Glory Dingulu; François Hofer; Michael Hofer; Andreas Woerner; Marie-Aliette Dommergues; Véronique Hentgen
Journal:  Clin Rheumatol       Date:  2021-01-13       Impact factor: 2.980

Review 2.  Vaccination in Children With Autoimmune Disorders and Treated With Various Immunosuppressive Regimens: A Comprehensive Review and Practical Guide.

Authors:  Geraldine Blanchard-Rohner
Journal:  Front Immunol       Date:  2021-08-02       Impact factor: 7.561

Review 3.  Immunogenicity and safety of routine vaccines in children and adolescents with rheumatic diseases on immunosuppressive treatment - a systematic review.

Authors:  Michèle Keller; Laure F Pittet; Petra Zimmermann
Journal:  Eur J Pediatr       Date:  2021-12-22       Impact factor: 3.183

4.  Vaccination completeness in children with rheumatic diseases: A longitudinal, observational multicenter cohort study in Switzerland.

Authors:  Tatjana Welzel; Jasmin Kuemmerle-Deschner; Constantin Sluka; Raffaella Carlomagno; Elvira Cannizzaro Schneider; Daniela Kaiser; Michael Hofer; Veronique Hentgen; Andreas Woerner
Journal:  Front Pediatr       Date:  2022-09-08       Impact factor: 3.569

5.  Real-life vaccination coverage in Slovak children with rheumatic diseases.

Authors:  Barbora Balažiová; Zuzana Kuková; Daša Mišíková; Katarína Novosedlíková; Tomáš Dallos
Journal:  Front Pediatr       Date:  2022-08-12       Impact factor: 3.569

6.  Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in patients with juvenile dermatomyositis: a real-world multicentre study.

Authors:  Ingrid Herta Rotstein Grein; Natalia Balera Ferreira Pinto; Noortje Groot; Camila Bertini Martins; Aline Lobo; Nadia Emi Aikawa; Cassia Barbosa; Maria Teresa Terreri; Aline Coelho Moreira da Fraga; Sheila Knupp Feitosa de Oliveira; Flavio Sztajnbok; Luciana B Paim Marques; Aline Garcia Islabão; Simone Appenzeller; Blanca Bica; Juliana de Oliveira Sato; Claudia Saad Magalhães; Virgínia Ferriani; Hella Pasmans; Rutger Schepp; Fiona van der Klis; Sytze de Roock; Nico Wulffraat; Gecilmara Salviato Pileggi
Journal:  Pediatr Rheumatol Online J       Date:  2020-11-11       Impact factor: 3.054

7.  The vaccine coverage and vaccine immunity status and risk factors of non-protective levels of antibodies against vaccines in children with juvenile idiopathic arthritis: cross-sectional Russian tertiary Centre study.

Authors:  Mikhail M Kostik; Natalia A Lubimova; Irina V Fridman; Olga V Goleva; Susanna M Kharit
Journal:  Pediatr Rheumatol Online J       Date:  2021-07-05       Impact factor: 3.054

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.